期刊文献+

维吾尔族与汉族女性乳腺癌分子分型的比较研究 被引量:7

Breast cancer molecular subtypes of Uygur and Han in Xinjiang of China
暂未订购
导出
摘要 目的研究比较维吾尔族(维族)与汉族女性乳腺癌分子分型特点,提高对乳腺癌分子分型的认识,更好地指导临床。方法采用2011St.Gallen最新乳腺癌分子分型方法,对170例经病理诊断证实的维、汉乳腺癌患者利用免疫组化及免疫荧光方法进行分子分型(Luminal A型、Luminal B型、HER-2过表达型和Basal-like型),结合临床病理资料,统计分析维族与汉族乳腺癌患者分子分型的异同点。结果维族与汉族患者的生育次数、肿瘤分级和肿瘤大小差异有统计意义;维族乳腺癌患者中组织学分级Ⅲ级所占比例高于汉族;维族乳腺癌患者在Her-2过表达型中年龄<35岁的比例高;在Luminal B型中月经状态为闭经和月经初潮年龄>15岁的维族患者比例高;在4种分子分型之间肿瘤的组织学分级差异有统计意义,HER-2过表达型和Basal-like型的患者倾向于高的组织学分级;在Luminal A型和Luminal B型中,维族乳腺癌患者的肿瘤直径大的比例高于汉族。结论维族与汉族乳腺癌的一般病理特性和分子分型存在一定的差异。维族乳腺癌患者具有一些预后差的特点。正确的认识不同民族间乳腺癌一般病理特性和分子分型的差异,对于临床乳腺癌的个体化治疗具有指导意义。 Objective To study and compared the differences about molecular subtype between Uygur and Han patients with breast cancer. Methods The new typing standard (2011 St. Gallen) was used to classi fy the molecular subtype of 170 breast caner cases. 4 immunohistochemical (IHC) markers (ER, PR, HER-2 and KI-67) were used to divide Uygur and Han breast cancer patients into 4 subtypes (Luminal A, Luminal B, HER-2 over expression and Basal-like), respectively. Then statistical analysis were used to evaluate difference in molecular subtype characteristics The Uygur patients had higher proportions of tumor HER-2 overexpression, age of menarche older than 15 by clinical and pathological characteristics. Results grade HI, age of onset less than 35 years in subtype years in subtype Basal-like and menopause in sub-type Luminal B. The tumor grade was different in 4 subtypes. The tumor size in Luminal A and Luminal B were different between Han and Uygur, Uygur patients had high proportion in large tumor. Conclusion There are some differences between Uygur and Compared with Han, Uygur patients had some Han in the pathological features and molecular subtypes. poor prognosis features. Correct understanding of breast cancer pathological characteristics and molecular typing differences between different ethnic, for clinical breast individualized treatment instructive.
出处 《新疆医科大学学报》 CAS 2013年第3期307-311,315,共6页 Journal of Xinjiang Medical University
基金 新疆维吾尔自治区科技支疆计划项目(201291172)
关键词 乳腺癌 分子分型 临床病理 维吾尔族 汉族 breast cancer molecular subtypes clinical pathology Uygur Han
  • 相关文献

参考文献18

  • 1Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes dealing with the diversity of breast Cancer: high- lights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J]. Ann On- col, 2011, 22(8),1736-1747.
  • 2Hammond ME, Hayes DF, Wolff AC, et al. American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer[J]. J Clin Oncol, 2010, 6(4) :195-197.
  • 3乳腺癌HER2检测指南(2009版)[J].中华病理学杂志,2009,38(12):836-840. 被引量:194
  • 4程虹,戴林,郭双平,等.乳腺及女性生殖器官肿瘤病理学和遗传学[M].北京:人民卫生出版社,2003:16-18.
  • 5Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumors[J]. Nature, 2000, 406 :747-752.
  • 6O'brien KM, Cole SR, Tse CK, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the carolina breast cancer study[J]. Clin Cancer Res, 2010, 16(24) :6100-6110.
  • 7Chuthapisith S, Permsapaya W, Warnnissorn M, et al. Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women[J]. Asian Pac J Cancer Prev, 2012, 13 (2) : 459- 462.
  • 8Telli ML, Chang ET, Kurian AW, et al. Asian ethnicity and breast cancer subtypes: a study from the California cancer reg- istry[J]. Breast Cancer Res Treat, 2011, 127(2):471-478.
  • 9胡欣,王昆华,包维民.基因分型对乳腺癌诊治和预后判断的指导作用[J].癌症进展,2009,7(2):141-145. 被引量:1
  • 10Leong SP, Shen ZZ, Liu TJ, et al. Is breast cancer the same disease in asian and western countries? [J].World J Surg, 2010, 34(10) :2308-2324.

二级参考文献28

  • 1赵云霞,刘德纯,沈蓉.乳腺癌446例临床病理分析[J].中国基层医药,2006,13(5):717-719. 被引量:5
  • 2<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:167
  • 3Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol, 2007,25 ( 33 ) : 5287-5312.
  • 4Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol,2007,25( 1 ) :118-145.
  • 5Hanna WM, Kwok K. Chromogenic in-situ hybridization: a viable alternative to fluorescence in-situ hybridization in the HER2 testing algorithm. Mod Pathol,2006,19(4) :481-487.
  • 6Gong Y, Sweet W, Duh YJ, et al. Chromogenic in situ hybridization is a reliable method for detecting HER2 gene status in breast cancer: a multicenter study using conventional scoring criteria and the new ASCO/CAP recommendations. Am J Clin Pathol,2009,131 (4) :490-497.
  • 7Dietel M, Ellis IO, Hofler H, et al. Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists. Virchows Arch ,2007,451 ( 1 ) : 19-25.
  • 8Pedersen M, Rasmussen BB. The correlation between dual-color chromogenic in situ hybridization and fluorescence in situ hybridization in assessing HER2 gene amplification in breast cancer. Diagn Mol Pathol,2009,18 (2) :96-102.
  • 9Yaziji H, Gown AM. Accuracy and precision in HER2/neu testing in breast cancer: are we there yet? Hum Pathol, 2004, 35 (2): 143-146.
  • 10Sauter G, Lee J, Bartlett JM, et al. Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologie considerations. J Clin Oncol, 2009,27 (8) : 1323- 1333.

共引文献204

同被引文献64

  • 1周娜,李秀梅,康有梁,马翔,任东萍,张靖.维吾尔族及汉族妇女乳腺肿块超声诊断对比分析[J].中华医学超声杂志(电子版),2011,8(10):2185-2189. 被引量:2
  • 2杨丽丽,梁莉萍,李景英,赵峰.新疆维吾尔族与汉族女性多中心性乳腺癌患者临床病理分析[J].肿瘤防治研究,2014,41(4):362-365. 被引量:3
  • 3徐小乐,靳雅丽,沈月平.CYP1 A1 MspI基因多态性与乳腺癌关系的Meta分析[J].苏州大学学报(医学版),2005,25(6):1078-1080. 被引量:5
  • 4陈莉颖,陈红风,付娜,叶媚娜.218例不同分子亚型浸润性乳腺癌患者的临床特征[J].现代肿瘤医学,2007,15(8):1094-1097. 被引量:12
  • 5李玉阳,刘奇.山东省乳腺疾病调查报告与乳腺癌危险因素分析[D].山东大学,2011.
  • 6徐勋,陆瑞芳,俞顺章,冯钦珠.上海市144例女性乳腺癌调查分析[J].中华预防医学杂志,1995,(05):316.
  • 7Dent R, Trudean M, Pritchard KI, et al. Triple - negative breast cancer:Clinical features and pattern a of recurrence [ J ]. Clin Cancer Res ,2007,13 ( 15 Pt 1 ) :4429 - 4434.
  • 8Kim M J, Ro JY, Alan SH, et al. Clinicopathologic signifi- cance of the basal - like subtype of breast cancer: A com- parison with hormone receptor and HER2/neu - overexpres- sion phenotype [ J J. Hum Pathol, 2006, 37 ( 9 ) : 1217 - 1226.
  • 9Kurebayashi J, Moriya T, Ishida T. The prevalence of intrin- sic subtypes and prognosis in breast cancer patients of dif- ferent races [ J ]. Breast,2007,16 ( supp 1 2 ) :72 - 77.
  • 10Hu ZY, Fan C, Oh DS, et al. The molecular portraits of breast tumors are conserved across microarray platforms [ J ]. BMC Genomics, 2006,7 : 96.

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部